Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. (Q39141673)
scientific article published on 11 June 2013
Language:
(P31) (Q13442814)
(P50) (Q55278042)
(P304) 2357-2365
(P407) (Q1860)
(P433) 12
(P478) 27
(P577) Tuesday, June 11, 2013
(P921) (Q467635)
(P1433) (Q6534498)
(P1476) "Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276" (language: en)
(P2093) J Schmidt
E Braggio
K M Kortuem
J B Egan
Y X Zhu
C S Xin
S E Palmer
V M Garbitt
D McCauley
M Kauffman
S Shacham
M Chesi
P L Bergsagel
A K Stewart
(P2860) (Q37445828)
(Q37693609)
(Q38075795)
(Q36675242)
(Q39256854)
(Q27674083)
(Q27670981)
(Q36234505)
(Q36206410)
(Q34263870)
(Q27012444)
(Q28247024)
(Q34207970)
(Q36204839)
(Q37347745)
(Q34756429)
(Q36727254)
(Q36478461)
(Q28290625)
(Q36531169)
(Q36254602)
(Q34624999)
(Q28202348)
(Q36135821)
(Q39276952)
(Q39432161)
(Q41175989)
(Q46198414)
(Q45941482)
(Q46977305)
(Q82214423)
other details
description scientific article published on 11 June 2013

External Links